ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,976.97
-1.13%
US Tech 100
21,079.20
-1.25%
Dow Jones
42,197.79
-1.79%
Brent Oil
73.815
0.00%
Bitcoin
105,001.55
-1.07%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Oric Pharmaceuticals Inc (ORIC) Quote

Oric Pharmaceuticals Inc

Oric Pharmaceuticals Inc (ORIC)

NASDAQ
9.63
-0.04
(-0.41%)
Closed June 14 4:00PM
15 min delayed - Upgrade to Realtime
9.62
-0.01
(-0.10%)
After Hours: 7:59PM
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
9.63
Bid
9.46
Ask
9.70
Volume
714,124
9.25 Day's Range 9.75
3.8951 52 Week Range 14.67
Market Cap
684.578M
Previous Close
9.67
Open
9.49
Last Trade
1
@
9.64
Last Trade Time
Financial Volume
$ 6,768,465
VWAP
9.478
Average Volume (3m)
1,181,047
Shares Outstanding
71,088,080
Dividend Yield
-
PE Ratio
-5.35
Earnings Per Share (EPS)
-1.8
Revenue
-
Net Profit
-127.85M

About Oric Pharmaceuticals Inc

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company h... ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101, ORIC-944, ORIC-114, and ORIC-533. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.oricpharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Oric Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ORIC. The last closing price for Oric Pharmaceuticals was $9.67. Over the last year, Oric Pharmaceuticals shares have traded in a share price range of $ 3.8951 to $ 14.67.

Oric Pharmaceuticals currently has 71,088,080 shares outstanding. The market capitalization of Oric Pharmaceuticals is $687.42 million. Oric Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.35.

Ask ADVFN Intelligence (AI)

ORIC Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
19 hours ago
ORIC (-0.41%)

Form S-3 - Registration statement under Securities Act of 1933
Edgar (US Regulatory)
June 11 2025
ORIC (-0.41%)

Form D - Notice of Exempt Offering of Securities
Edgar (US Regulatory)
June 06 2025
ORIC (-0.41%)

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Edgar (US Regulatory)
June 05 2025
ORIC (-0.41%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.151.582278481019.4810.078.9610396059.59332531CS
44.89103.1645569624.7410.074.6320847717.89427432CS
122.2129.78436657687.4210.073.895111810476.7829785CS
261.214.23487544488.4314.673.895110497277.93007171CS
521.7321.89873417727.914.673.89517550398.42357281CS
1565.53134.878048784.116.652.365342187.83314601CS
260-23.81-71.2021531133.4440.812.3643572210.39664784CS

ORIC - Frequently Asked Questions (FAQ)

What is the current Oric Pharmaceuticals share price?
The current share price of Oric Pharmaceuticals is $ 9.63
How many Oric Pharmaceuticals shares are in issue?
Oric Pharmaceuticals has 71,088,080 shares in issue
What is the market cap of Oric Pharmaceuticals?
The market capitalisation of Oric Pharmaceuticals is USD 687.42M
What is the 1 year trading range for Oric Pharmaceuticals share price?
Oric Pharmaceuticals has traded in the range of $ 3.8951 to $ 14.67 during the past year
What is the PE ratio of Oric Pharmaceuticals?
The price to earnings ratio of Oric Pharmaceuticals is -5.35
What is the reporting currency for Oric Pharmaceuticals?
Oric Pharmaceuticals reports financial results in USD
What is the latest annual profit for Oric Pharmaceuticals?
The latest annual profit of Oric Pharmaceuticals is USD -127.85M
What is the registered address of Oric Pharmaceuticals?
The registered address for Oric Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Oric Pharmaceuticals website address?
The website address for Oric Pharmaceuticals is www.oricpharma.com
Which industry sector does Oric Pharmaceuticals operate in?
Oric Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RBNERobin Energy Ltd
$ 13.85
(313.43%)
101.81M
OPOceanPal Inc
$ 1.63
(125.45%)
80.28M
LGHLWLion Group Holding Ltd
$ 0.0052
(116.67%)
6.87M
NEONNeonode Inc
$ 16.83
(68.47%)
4.78M
ICONIcon Energy Corporation
$ 2.90
(62.01%)
59.04M
SBETSharpLink Gaming Inc
$ 9.2275
(-71.63%)
41.92M
AIHSSenmiao Technology Ltd
$ 0.381
(-63.01%)
16.8M
CHSNChanson International Holding
$ 0.22
(-60.00%)
15.15M
KWMK Wave Media Ltd
$ 2.91
(-50.43%)
2.59M
JZXNJiuzi Holdings Inc
$ 1.56
(-46.39%)
2.24M
HCTIHealthcare Triangle Inc
$ 0.0201
(-33.00%)
856.89M
GNLNGreenlane Holdings Inc
$ 0.0101
(-34.42%)
792.34M
CGBSCrown LNG Holdings Ltd
$ 0.1104
(31.43%)
788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.655
(3.81%)
246.13M
NVDANVIDIA Corporation
$ 141.97
(-2.09%)
180.81M

ORIC Discussion

View Posts
stocksrising stocksrising 4 months ago
Is under $10 a good buy or short? TIA
👍️0
Monksdream Monksdream 9 months ago
ORIC under $10
👍️0
Monksdream Monksdream 11 months ago
ORIC under $10
👍️0
Monksdream Monksdream 11 months ago
ORIC under $10
👍️0
Monksdream Monksdream 1 year ago
ORIC 10Q due 5/6
👍️0
Monksdream Monksdream 1 year ago
ORIC under $10
👍️0
Monksdream Monksdream 1 year ago
ORIC 10Q due 3/16
👍️0
Monksdream Monksdream 1 year ago
ORIC new 52 week high
👍️0
Monksdream Monksdream 1 year ago
ORIC new 52 week high
👍️0
Monksdream Monksdream 1 year ago
ORIC new 52 week high
👍️0
Monksdream Monksdream 1 year ago
ORIC new 52 weewk high
👍️0
Monksdream Monksdream 1 year ago
ORIC new 52 week high
👍️0
TheFinalCD TheFinalCD 2 years ago
$ORIC LOOKS LIKE $6 COMING
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC: Tapped $5.40....... still got steam

It ain't over yet





GO $ORIC
👍️0
DH112 DH112 2 years ago
Today is green fields
👍️0
TheFinalCD TheFinalCD 2 years ago
Pfizer will pay $4.65 per share for 5,376,344 of Oric's common shares, for a total of $25 million. The companies plan to move the treatment into a Phase 2 clinical trial in combination with elranatamab, Pfizer's investigational treatment of multiple myeloma

https://finance.yahoo.com/news/oric-pharmaceuticals-announces-clinical-development-224800151.html
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC: 5.25 now........................... lets get to $10

I know you can do it babyyyyyyyyyyyyyyyyy


GO $ORIC
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC : Now at 4.90

YESsssssssssssssss............ this is very impressive news with deal with Pfizer.

Me likes it


GO $ORIC
👍️0
crudeoil24 crudeoil24 2 years ago
Shares of Oric Pharmaceuticals Inc. jumped nearly 60% to $4.79 in premarket trading Thursday after the company agreed to sell $25 million in shares to Pfizer Inc.

The clinical-stage oncology company said Wednesday evening that Pfizer has agreed to buy nearly 5.4 million shares of Oric's common stock for $4.65 apiece.

The investment is part of a clinical development collaboration between the two companies on a Phase 2 study examining Oric's ORIC-533 treatment for multiple myeloma, the companies said.

The companies said the collaboration would potentially advance the treatment into a combination study with Pfizer's elranatamab, an investigational treatment for multiple myeloma.


Write to Dean Seal at dean.seal@wsj.com


(END) Dow Jones Newswires

December 22, 2022 07:25 ET (12:25 GMT)
👍️0
makinezmoney makinezmoney 2 years ago
$ORIC: BOOOoommmmmmm........... Pfiizer invests $25Milly in ORIC

Letssssssss goooooooooooooooooo.


Added 5k shares here at 4.30

Great NEWS


https://www.tipranks.com/news/oric-pharmaceuticals-nasdaqoric-stock-spikes-on-pfizer-deal

GO $ORIC
👍️0

Your Recent History

NASDAQ
ORIC
Oric Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads